Inside MS, September 22nd, 1999
At or on the further side of ... not subject to limits ... Yes, this is the last issue of InsideMS for this century. Beyond lies the year 2000 and a whole new set of opportunities.... The Society has already exploited many opportunities to move beyond its original boundaries. New scientific knowledge has brought us to a halfway point for MS therapies. Avonex, Betaseron, and Copaxone, the new ABCs of MS, do not cure MS--and cure is our ultimate goal. But they are proven to slow down the underlying process of the disease. We have moved beyond treating only symptoms. The Society moved beyond o...
HighBeam Research, Free Preview: 'Beyond \be-and\.'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
